Higher Depression and PTSD Prevalence Among Women Using Hormone Replacement Therapy (HRT) May Be Due to Shared Genetic Effects

被引：0
|
作者：
Duncan, Laramie [1 ]
机构：
[1] Stanford Univ, Redwood City, CA USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2020年 / 45卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
8.1
引用
收藏
页码：9 / 9
页数：1
相关论文
共 38 条
  • [31] Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy
    Brinton, LA
    Brogan, DR
    Coates, RJ
    Swanson, CA
    Potischman, N
    Stanford, JL
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 1998, 5 (03): : 145 - 151
  • [32] Acute Exercise Effects on Craving and Withdrawal Symptoms among Women Attempting to Quit Smoking Using Nicotine Replacement Therapy
    Harper, Therese
    Fitzgeorge, Lyndsay
    Tritter, Amelia
    Prapavessis, Harry
    JOURNAL OF SMOKING CESSATION, 2012, 7 (02): : 72 - 79
  • [33] Life prevalence of hormone replacement therapy and profile of users have not changed among women with self-reported menopause in the last two decades in Porto, Portugal
    Lucas, R.
    Barros, H.
    CLIMACTERIC, 2008, 11 (01) : 26 - 31
  • [34] Depression, hormone therapy, and the menopausal transition among women aged 45 to 64 years using Canadian Longitudinal Study on aging baseline data
    Shea, Alison K.
    Sohel, Nazmul
    Gilsing, Anne
    Mayhew, Alexandra J.
    Griffith, Lauren E.
    Raina, Parminder
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (07): : 763 - 770
  • [35] Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997
    Bakken, K
    Eggen, AE
    Lund, E
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2004, 83 (09) : 850 - 856
  • [36] The effects of oral hormone replacement therapy (HRT) on C-reactive-reactive protein and other inflammatory markers in women with previous venous thromboembolism: Results from a randomized, double-blind, clinical trial.
    Eilertsen, AL
    Hoibraaten, E
    Sandvik, L
    Andersen, TO
    Mowinckel, MC
    Sandset, PM
    BLOOD, 2003, 102 (11) : 316A - 316A
  • [37] Does the progesterone receptor genetic polymorphism+331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study
    Bouaziz, Elodie
    Canonico, Marianne
    Verstuyft, Celine
    Carcaillon, Laure
    Martin, Frederic
    Scarabin, Pierre-Yves
    Guiochon-Mantel, Anne
    MATURITAS, 2009, 64 (02) : 136 - 138
  • [38] The interaction between menopausal hormone replacement therapy and the 2q35 (rs13387042) breast cancer risk variant explains the effect modification by genetic ancestry among Hispanic women
    Fejerman, Laura
    Stern, Mariana C.
    Ziv, Elad
    John, Esther M.
    Torres-Mejia, Gabriela
    Hines, Lisa M.
    Wolff, Roger
    Baumgartner, Kathy B.
    Giuliano, Anna
    Slaftery, Martha L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (11)
1234